International Journal of Chronic Obstructive Pulmonary Disease
Volume 15, 2020 - Issue
Original Research
FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease
, 
, , , , , , , , , , & show all
Peter Lange3 Medical Department, Herlev and Gentofte Hospital, Herlev, Denmark;4 Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0003-0401-0081
https://orcid.org/0000-0003-0401-0081, Julie A Anderson5 Research & Development, GlaxoSmithKline, Middlesex, UKhttps://orcid.org/0000-0003-1313-9725
https://orcid.org/0000-0003-1313-9725, , , , , Courtney Crim10 Research & Development, GlaxoSmithKline, Research Triangle Park, NC, USAhttps://orcid.org/0000-0002-3391-2490
https://orcid.org/0000-0002-3391-2490, , Fernando J Martinez11 Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, USAhttps://orcid.org/0000-0002-2412-3182
https://orcid.org/0000-0002-2412-3182, , & Jørgen Vestbo1 Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK;2 Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester, UKhttps://orcid.org/0000-0001-6355-6362
https://orcid.org/0000-0001-6355-6362 show all